Overview

Rupatadine in Patients With Ulcerative Colitis

Status:
RECRUITING
Trial end date:
2026-10-21
Target enrollment:
Participant gender:
Summary
Ulcerative colitis (UC) is a chronic inflammatory condition that primarily targets the large intestine. Although substantial progress has been made in treatment modalities-especially with the development of immunomodulatory drugs and biologic therapies-managing UC continues to present significant challenges. At present, there is no definitive cure, and current treatment strategies are largely focused on controlling inflammation, relieving symptoms, and halting disease progression
Phase:
PHASE2
Details
Lead Sponsor:
Alexandria University
Treatments:
Mesalamine
rupatadine